Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment.

Hong-Joon ShinJoon-Young YoonYoung-Ok NaJae-Kyeong LeeBo Gun KhoTae-Ok KimYu-Il KimSung-Chul LimSae-Hee JeongYong Soo Kwon

Published in: PloS one (2023)

Although most patients treated with PZA developed hyperuricemia, it was not associated with MACE development. Hyperuricemia during TB treatment was associated with better outcomes, possibly due to consistent adherence to TB treatment.

Keyphrases

cardiovascular events
mycobacterium tuberculosis
coronary artery disease
type diabetes
metabolic syndrome
insulin resistance
human immunodeficiency virus
hiv infected